Tuesday
David Webb - Early assessment of cost-effectiveness
Michael Rawlins - Has NICE produced clinical excellence?
Herbie Newell - Biomarkers and the developments of targeted cancer treatements - clinical pharmacology comes of age!
Duncan Jodrell - New designs in cancer trials
Petra Thuermann - Surveillance for ADRs - have we moved on from spontaneous reports?
Greg Lip - Atrial fibrillation - what is optimal treatment now?
Garret FitzGerald - Translational medicine: past successes and future challenges
Nicholas Moore - The role of pharmacoepidemiology in pharmacovigilance
Tom MacDonald - Record linkage studies in research
Peter Sandercock - What have we learned from the stroke trials?
Else Tonnesen - Strategies to treat sepsis - old and new
Ulrich Kunzendorf - New pharmacologic therapies for acute renal failure
Peter Davey - Overcoming the challenge of resistance
Yves Bottiger - Drug information services today - from databases to patients and back to databases
John Ahlner & Trond Aamo - Therapeutic drug monitoring and drug toxicology
Erik Eliasson - Pharmacogenetic services
Morten Andersen - Pharmacoepidemiological services
|
Congress of the European Association for Clinical Pharmacology and TherapeuticsEdinburgh, Scotland 12 - 15th July 2009